Biotech Research
Filter News
Found 1,929 articles
-
DaVita Clinical Research Study Indicates Effectiveness of mRNA COVID-19 Vaccines in Dialysis Patients
11/29/2021
Dialysis patients who received mRNA COVID-19 vaccines had a lower risk of COVID-19 diagnosis post-vaccination and were less likely to be hospitalized or die following breakthrough infection than unvaccinated patients, according to a DaVita Clinical Research study published online ahead of print by the Journal of the American Society of Nephrology.
-
Study Confirms Importance of Self-Management Program for Adolescents with Arthritis
11/29/2021
Self-management programs can help adolescents living with juvenile idiopathic arthritis manage their disease as they enter adulthood, according to new research.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones from this week.
-
ATCC Announces Award from National Institute of Allergy and Infectious Diseases (NIAID) to Develop Research Capabilities in Infectious, Immunologic and Allergic Diseases
11/23/2021
ATCC, the world’s premier biological materials management and standards organization, announced that it has been awarded a seven-year, Indefinite Delivery/Indefinite Quantity contract with a ceiling value of $545 million by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
-
Promising COVID-19 Therapeutic Drug to start Phase 3 Clinical Trial in the United StatesPulmonem and the Research Institute of the McGill University Health Centre announce recruitment of first US-based patients
11/22/2021
Pulmonem Inc. and the Research Institute of the McGill University Health Centre today announced that they have successfully started recruiting US-based patients for the Phase 3 Clinical Trial (ClinicalTrials.gov Identifier: NCT04935476) of the promising COVID-19 therapeutic drug PULM-001.
-
A recent study has highlighted the need for more stringent Phase II trial protocols on the basis that over 80% of candidate oncology treatments that go into Phase III failed to achieve OS goals.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones including T helper cells for COVID-19, new gene found that could contribute to type 1 diabetes and more.
-
The Richard King Mellon Foundation has awarded a $100 million gift to the University of Pittsburgh and approved a $150 million grant for Carnegie Mellon University.
-
Biopharma and life sciences companies from across the globe provide updates. Belgium-based Galapagos NV won European approval for Jyseleca for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).
-
Cellevolve Launches with Acclaimed Investors and Pivotal Manufacturing Partnership, Focused on Accelerating the Commercialization of Novel Cell Therapies
11/18/2021
Cellevolve Bio, a development and commercialization company focused on cell therapies, announced its launch following the successful close of seed financing and an exclusive manufacturing partnership with National Resilience, Inc., a biopharmaceutical manufacturing company supply.
-
Scientists from Brigham and Women's Hospital are ready to start a clinical trial that will evaluate the use of an intranasal vaccine to prevent Alzheimer's disease.
-
Researchers have published a study of a woman being called the "Esperanza patient," one of what researchers call "elite controllers," who seem to eradicate HIV naturally.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Scientists Explore SARS-CoV-2 Mega Vaccine
11/11/2021
Scientists are conducting research into the possibility of creating a vaccine that activates T cells that targets not just SARS-CoV-2 but also its variations, even the ones that cause common colds. -
Feinstein Institutes’ Advancing Women in Science and Medicine Sets Research Funding Record
11/10/2021
The Feinstein Institutes for Medical Research, the science arm of Northwell Health, recently recognized 41 women scientists who received a record-breaking $541,000 in research funding this year.
-
DNA Script to Develop Next Generation of Enzymatic DNA Synthesis Printers with $2.2 Million Grant Award from the National Human Genome Research Institute of the NIH
11/9/2021
DNA Script, a leader in benchtop enzymatic DNA synthesis, announced that the company has received a $2.2 million grant award from the National Human Genome Research Institute of the National Institutes of Health to support the ongoing development of next generation printers to enzymatically print synthetic DNA and RNA as a follow-on to their recently launched SYNTAX System.
-
Prevencio and Seattle Children’s Research Institute Present Highly Accurate, AI-driven HART KD Data on First Blood Test for Kawasaki Disease at Premiere International Kawasaki Disease Scientific Sessions
11/9/2021
Prevencio, Inc. announces presentation of highly accurate data on an Artificial Intelligence -driven blood test for Kawasaki disease at the International Kawasaki Disease Scientific Sessions in Japan.
-
Berkeley Lights Reports Third Quarter 2021 Financial Results Record third quarter 2021 revenue grew 34% year over year
11/4/2021
Berkeley Lights, Inc., a leader in Digital Cell Biology, reported financial results for the quarter ended September 30, 2021.
-
DaVita Clinical Research to Present New Findings at American Society of Nephrology Kidney Week 2021
11/4/2021
DaVita Clinical Research will present eight research abstracts from company representatives and medical professionals during the American Society of Nephrology Kidney Week occurring Nov. 4–7, 2021.
-
City of Hope Doctors Present New Research on Cancer Immunotherapies
11/4/2021
New data on bispecific antibodies and stem cell transplants will be presented in person and virtually at the American Society of Hematology Annual Meeting Dec. 11 to 14.